Recro Pharma GAAP EPS of $0.04 beats by $0.11, revenue of $22.3M beats by $0.89M

Stock Information for Societal CDMO, I

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Societal CDMO, I

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Societal CDMO Reports Inducement Grants for New Staff
Societal CDMO Reports Third Quarter 2023 Financial Results
Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
Societal CDMO Reports Inducement Grants for New Staff
Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.